Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 23 entries
Sorted by: Best Match Show Resources per page
Correction for Patro et al., Shift in Monocyte Apoptosis with Increasing Viral Load and Change in Apoptosis-Related ISG/Bcl2 Family Gene Expression in Chronically HIV-1-Infected Subjects.

Journal of virology

Patro SC, Pal S, Bi Y, Lynn K, Mounzer KC, Kostman JR, Davuluri RV, Montaner LJ.
PMID: 26041838
J Virol. 2015 Jul;89(13):6970. doi: 10.1128/JVI.00735-15.

No abstract available.

Cite
Patro SC, Pal S, Bi Y, et al. Correction for Patro et al., Shift in Monocyte Apoptosis with Increasing Viral Load and Change in Apoptosis-Related ISG/Bcl2 Family Gene Expression in Chronically HIV-1-Infected Subjects. J Virol. 2015;89(13):6970doi: 10.1128/JVI.00735-15.
Patro, S. C., Pal, S., Bi, Y., Lynn, K., Mounzer, K. C., Kostman, J. R., Davuluri, R. V., & Montaner, L. J. (2015). Correction for Patro et al., Shift in Monocyte Apoptosis with Increasing Viral Load and Change in Apoptosis-Related ISG/Bcl2 Family Gene Expression in Chronically HIV-1-Infected Subjects. Journal of virology, 89(13), 6970. https://doi.org/10.1128/JVI.00735-15
Patro, Sean C, et al. "Correction for Patro et al., Shift in Monocyte Apoptosis with Increasing Viral Load and Change in Apoptosis-Related ISG/Bcl2 Family Gene Expression in Chronically HIV-1-Infected Subjects." Journal of virology vol. 89,13 (2015): 6970. doi: https://doi.org/10.1128/JVI.00735-15
Patro SC, Pal S, Bi Y, Lynn K, Mounzer KC, Kostman JR, Davuluri RV, Montaner LJ. Correction for Patro et al., Shift in Monocyte Apoptosis with Increasing Viral Load and Change in Apoptosis-Related ISG/Bcl2 Family Gene Expression in Chronically HIV-1-Infected Subjects. J Virol. 2015 Jul;89(13):6970. doi: 10.1128/JVI.00735-15. PMID: 26041838; PMCID: PMC4468485.
Copy Download .nbib Format: NLM
Modelling farmer choices for water security measures in the Litani river basin in Lebanon.

The Science of the total environment

Alcon F, Tapsuwan S, Brouwer R, Yunes M, Mounzer O, de-Miguel MD.
PMID: 30077853
Sci Total Environ. 2019 Jan 10;647:37-46. doi: 10.1016/j.scitotenv.2018.07.410. Epub 2018 Jul 30.

Lebanon is facing an increasing water supply deficit due to the increasing demand for freshwater, decreasing surface and groundwater resources and malfunctioning water governance structures. Technological and policy changes are needed to alleviate the impact of water scarcity and...

Cite
Alcon F, Tapsuwan S, Brouwer R, et al. Modelling farmer choices for water security measures in the Litani river basin in Lebanon. Sci Total Environ. 2018;647:37-46doi: 10.1016/j.scitotenv.2018.07.410.
Alcon, F., Tapsuwan, S., Brouwer, R., Yunes, M., Mounzer, O., & de-Miguel, M. D. (2019). Modelling farmer choices for water security measures in the Litani river basin in Lebanon. The Science of the total environment, 64737-46. https://doi.org/10.1016/j.scitotenv.2018.07.410
Alcon, F, et al. "Modelling farmer choices for water security measures in the Litani river basin in Lebanon." The Science of the total environment vol. 647 (2019): 37-46. doi: https://doi.org/10.1016/j.scitotenv.2018.07.410
Alcon F, Tapsuwan S, Brouwer R, Yunes M, Mounzer O, de-Miguel MD. Modelling farmer choices for water security measures in the Litani river basin in Lebanon. Sci Total Environ. 2019 Jan 10;647:37-46. doi: 10.1016/j.scitotenv.2018.07.410. Epub 2018 Jul 30. PMID: 30077853.
Copy Download .nbib Format: NLM
Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide.

Frontiers in pharmacology

Lalley-Chareczko L, Hiserodt E, Moorthy G, Zuppa A, Mounzer K, Koenig H.
PMID: 32265700
Front Pharmacol. 2020 Mar 19;11:286. doi: 10.3389/fphar.2020.00286. eCollection 2020.

No abstract available.

Cite
Lalley-Chareczko L, Hiserodt E, Moorthy G, et al. Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide. Front Pharmacol. 2020;11:286doi: 10.3389/fphar.2020.00286.
Lalley-Chareczko, L., Hiserodt, E., Moorthy, G., Zuppa, A., Mounzer, K., & Koenig, H. (2020). Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide. Frontiers in pharmacology, 11286. https://doi.org/10.3389/fphar.2020.00286
Lalley-Chareczko, Linden, et al. "Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide." Frontiers in pharmacology vol. 11 (2020): 286. doi: https://doi.org/10.3389/fphar.2020.00286
Lalley-Chareczko L, Hiserodt E, Moorthy G, Zuppa A, Mounzer K, Koenig H. Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide. Front Pharmacol. 2020 Mar 19;11:286. doi: 10.3389/fphar.2020.00286. eCollection 2020. PMID: 32265700; PMCID: PMC7096572.
Copy Download .nbib Format: NLM
Difficult Discharges to Skilled Nursing Facilities Attributed to Multiple Sclerosis Medications: An Observational Study.

The Neurohospitalist

Munger KC, George BP, Samkoff LM, Robb JF.
PMID: 32373269
Neurohospitalist. 2020 Apr;10(2):82-87. doi: 10.1177/1941874419855909. Epub 2019 Jun 13.

BACKGROUND: The costs of multiple sclerosis (MS) disease-modifying therapies (DMTs) and certain symptomatic treatments (ie, dalfampridine [DFP]) are high. Consolidated billing models require that medication costs be covered by skilled nursing facilities (SNFs) after hospitalization. As a result, patients...

Cite
Munger KC, George BP, Samkoff LM, et al. Difficult Discharges to Skilled Nursing Facilities Attributed to Multiple Sclerosis Medications: An Observational Study. Neurohospitalist. 2019;10(2):82-87doi: 10.1177/1941874419855909.
Munger, K. C., George, B. P., Samkoff, L. M., & Robb, J. F. (2020). Difficult Discharges to Skilled Nursing Facilities Attributed to Multiple Sclerosis Medications: An Observational Study. The Neurohospitalist, 10(2), 82-87. https://doi.org/10.1177/1941874419855909
Munger, Kathleen C, et al. "Difficult Discharges to Skilled Nursing Facilities Attributed to Multiple Sclerosis Medications: An Observational Study." The Neurohospitalist vol. 10,2 (2020): 82-87. doi: https://doi.org/10.1177/1941874419855909
Munger KC, George BP, Samkoff LM, Robb JF. Difficult Discharges to Skilled Nursing Facilities Attributed to Multiple Sclerosis Medications: An Observational Study. Neurohospitalist. 2020 Apr;10(2):82-87. doi: 10.1177/1941874419855909. Epub 2019 Jun 13. PMID: 32373269; PMCID: PMC7191658.
Copy Download .nbib Format: NLM
Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era.

Open forum infectious diseases

Agha ME, Blake M, Chilleo C, Wells A, Haidar G.
PMID: 34337100
Open Forum Infect Dis. 2021 Jun 30;8(7):ofab353. doi: 10.1093/ofid/ofab353. eCollection 2021 Jul.

We measured severe acute respiratory syndrome coronavirus 2 immunoglobulin G responses in 67 patients with hematological malignancies after 2 messenger RNA vaccine doses. Forty-six percent were nonresponders; patients with B-cell chronic lymphocytic leukemia were at highest risk (77% nonresponders)....

Cite
Agha ME, Blake M, Chilleo C, et al. Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era. Open Forum Infect Dis. 2021;8(7):ofab353doi: 10.1093/ofid/ofab353.
Agha, M. E., Blake, M., Chilleo, C., Wells, A., & Haidar, G. (2021). Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era. Open forum infectious diseases, 8(7), ofab353. https://doi.org/10.1093/ofid/ofab353
Agha, Mounzer E, et al. "Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era." Open forum infectious diseases vol. 8,7 (2021): ofab353. doi: https://doi.org/10.1093/ofid/ofab353
Agha ME, Blake M, Chilleo C, Wells A, Haidar G. Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era. Open Forum Infect Dis. 2021 Jun 30;8(7):ofab353. doi: 10.1093/ofid/ofab353. eCollection 2021 Jul. PMID: 34337100; PMCID: PMC8320282.
Copy Download .nbib Format: NLM
Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs.

AIDS (London, England)

Hsu R, Brunet L, Fusco JS, Mounzer K, Vannappagari V, Henegar CE, Van Wyk J, Curtis L, Lo J, Fusco GP.
PMID: 33048874
AIDS. 2021 Jan 01;35(1):81-90. doi: 10.1097/QAD.0000000000002718.

OBJECTIVES: To describe the prevalence and incidence of prediabetes and type 2 diabetes mellitus (T2DM) among people living with HIV (PLHIV) and evaluate the association between antiretroviral therapy (ART) initiation with dolutegravir (DTG), elvitegravir/cobicistat (EVG/c), raltegravir (RAL), or boosted...

Cite
Hsu R, Brunet L, Fusco JS, et al. Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs. AIDS. 2021;35(1):81-90doi: 10.1097/QAD.0000000000002718.
Hsu, R., Brunet, L., Fusco, J. S., Mounzer, K., Vannappagari, V., Henegar, C. E., Van Wyk, J., Curtis, L., Lo, J., & Fusco, G. P. (2021). Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs. AIDS (London, England), 35(1), 81-90. https://doi.org/10.1097/QAD.0000000000002718
Hsu, Ricky, et al. "Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs." AIDS (London, England) vol. 35,1 (2021): 81-90. doi: https://doi.org/10.1097/QAD.0000000000002718
Hsu R, Brunet L, Fusco JS, Mounzer K, Vannappagari V, Henegar CE, Van Wyk J, Curtis L, Lo J, Fusco GP. Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs. AIDS. 2021 Jan 01;35(1):81-90. doi: 10.1097/QAD.0000000000002718. PMID: 33048874.
Copy Download .nbib Format: NLM
Surface Response Based Modeling of Liposome Characteristics in a Periodic Disturbance Mixer.

Micromachines

López RR, Ocampo I, Sánchez LM, Alazzam A, Bergeron KF, Camacho-León S, Mounier C, Stiharu I, Nerguizian V.
PMID: 32106424
Micromachines (Basel). 2020 Feb 25;11(3). doi: 10.3390/mi11030235.

Liposomes nanoparticles (LNPs) are vesicles that encapsulate drugs, genes, and imaging labels for advanced delivery applications. Control and tuning liposome physicochemical characteristics such as size, size distribution, and zeta potential are crucial for their functionality. Liposome production using micromixers...

Cite
López RR, Ocampo I, Sánchez LM, et al. Surface Response Based Modeling of Liposome Characteristics in a Periodic Disturbance Mixer. Micromachines (Basel). 2020;11(3)doi: 10.3390/mi11030235.
López, R. R., Ocampo, I., Sánchez, L. M., Alazzam, A., Bergeron, K. F., Camacho-León, S., Mounier, C., Stiharu, I., & Nerguizian, V. (2020). Surface Response Based Modeling of Liposome Characteristics in a Periodic Disturbance Mixer. Micromachines, 11(3), . https://doi.org/10.3390/mi11030235
López, Rubén R, et al. "Surface Response Based Modeling of Liposome Characteristics in a Periodic Disturbance Mixer." Micromachines vol. 11,3 (2020). doi: https://doi.org/10.3390/mi11030235
López RR, Ocampo I, Sánchez LM, Alazzam A, Bergeron KF, Camacho-León S, Mounier C, Stiharu I, Nerguizian V. Surface Response Based Modeling of Liposome Characteristics in a Periodic Disturbance Mixer. Micromachines (Basel). 2020 Feb 25;11(3). doi: 10.3390/mi11030235. PMID: 32106424; PMCID: PMC7143066.
Copy Download .nbib Format: NLM
Tetracycline derivative minocycline inhibits autophagy and inflammation in concanavalin-a-activated human hepatoma cells.

Gene regulation and systems biology

Desjarlais M, Pratt J, Lounis A, Mounier C, Haidara K, Annabi B.
PMID: 24634581
Gene Regul Syst Bio. 2014 Mar 04;8:63-73. doi: 10.4137/GRSB.S13946. eCollection 2014.

Inhibition of soluble matrix metalloproteinase (MMP) activity is among the non-antibiotic cellular effects exerted by the anti-inflammatory tetracycline derivative minocycline. The impact of minocycline on the signal transduction functions of membrane-bound MMPs is however unknown. We assessed minocycline in...

Cite
Desjarlais M, Pratt J, Lounis A, et al. Tetracycline derivative minocycline inhibits autophagy and inflammation in concanavalin-a-activated human hepatoma cells. Gene Regul Syst Bio. 2014;8:63-73doi: 10.4137/GRSB.S13946.
Desjarlais, M., Pratt, J., Lounis, A., Mounier, C., Haidara, K., & Annabi, B. (2014). Tetracycline derivative minocycline inhibits autophagy and inflammation in concanavalin-a-activated human hepatoma cells. Gene regulation and systems biology, 863-73. https://doi.org/10.4137/GRSB.S13946
Desjarlais, Michel, et al. "Tetracycline derivative minocycline inhibits autophagy and inflammation in concanavalin-a-activated human hepatoma cells." Gene regulation and systems biology vol. 8 (2014): 63-73. doi: https://doi.org/10.4137/GRSB.S13946
Desjarlais M, Pratt J, Lounis A, Mounier C, Haidara K, Annabi B. Tetracycline derivative minocycline inhibits autophagy and inflammation in concanavalin-a-activated human hepatoma cells. Gene Regul Syst Bio. 2014 Mar 04;8:63-73. doi: 10.4137/GRSB.S13946. eCollection 2014. PMID: 24634581; PMCID: PMC3948715.
Copy Download .nbib Format: NLM
ABCD2 Score and Large-Artery Atherosclerosis.

The Neurohospitalist

Bhatt A, Farooq MU, Safdar A, Hejabian S, Razak A, Hussain SI, Kassab MY, Majid A.
PMID: 23983858
Neurohospitalist. 2012 Jan;2(1):12-7. doi: 10.1177/1941874411418239.

BACKGROUND AND PURPOSE: Extracranial stenosis (ECS) or intracranial stenosis (ICS) are independent risk factors for stroke after transient ischemic attack (TIA). We examined the association of the age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score,...

Cite
Bhatt A, Farooq MU, Safdar A, et al. ABCD2 Score and Large-Artery Atherosclerosis. Neurohospitalist. 2012;2(1):12-7doi: 10.1177/1941874411418239.
Bhatt, A., Farooq, M. U., Safdar, A., Hejabian, S., Razak, A., Hussain, S. I., Kassab, M. Y., & Majid, A. (2012). ABCD2 Score and Large-Artery Atherosclerosis. The Neurohospitalist, 2(1), 12-7. https://doi.org/10.1177/1941874411418239
Bhatt, Archit, et al. "ABCD2 Score and Large-Artery Atherosclerosis." The Neurohospitalist vol. 2,1 (2012): 12-7. doi: https://doi.org/10.1177/1941874411418239
Bhatt A, Farooq MU, Safdar A, Hejabian S, Razak A, Hussain SI, Kassab MY, Majid A. ABCD2 Score and Large-Artery Atherosclerosis. Neurohospitalist. 2012 Jan;2(1):12-7. doi: 10.1177/1941874411418239. PMID: 23983858; PMCID: PMC3726095.
Copy Download .nbib Format: NLM
Stearic acid content of abdominal adipose tissues in obese women.

Nutrition & diabetes

Caron-Jobin M, Mauvoisin D, Michaud A, Veilleux A, Noël S, Fortier MP, Julien P, Tchernof A, Mounier C.
PMID: 23154679
Nutr Diabetes. 2012 Jan 30;2:e23. doi: 10.1038/nutd.2011.19.

OBJECTIVE: Subcutaneous (SC) adipose tissue stearic acid (18:0) content and stearoyl-CoA desaturase-1 (SCD1)-mediated production of oleic acid (18:1) have been suggested to be altered in obesity. The objective of our study was to examine abdominal adipose tissue fatty acid...

Cite
Caron-Jobin M, Mauvoisin D, Michaud A, et al. Stearic acid content of abdominal adipose tissues in obese women. Nutr Diabetes. 2012;2:e23doi: 10.1038/nutd.2011.19.
Caron-Jobin, M., Mauvoisin, D., Michaud, A., Veilleux, A., Noël, S., Fortier, M. P., Julien, P., Tchernof, A., & Mounier, C. (2012). Stearic acid content of abdominal adipose tissues in obese women. Nutrition & diabetes, 2e23. https://doi.org/10.1038/nutd.2011.19
Caron-Jobin, M, et al. "Stearic acid content of abdominal adipose tissues in obese women." Nutrition & diabetes vol. 2 (2012): e23. doi: https://doi.org/10.1038/nutd.2011.19
Caron-Jobin M, Mauvoisin D, Michaud A, Veilleux A, Noël S, Fortier MP, Julien P, Tchernof A, Mounier C. Stearic acid content of abdominal adipose tissues in obese women. Nutr Diabetes. 2012 Jan 30;2:e23. doi: 10.1038/nutd.2011.19. PMID: 23154679; PMCID: PMC3302147.
Copy Download .nbib Format: NLM
Intra-abdominal adipose depot variation in adipogenesis, lipogenesis, angiogenesis, and fibrosis gene expression and relationships with insulin resistance and inflammation in premenopausal women with severe obesity.

Journal of physiology and biochemistry

Clément AA, Lacaille M, Lounis MA, Biertho LD, Richard D, Lemieux I, Bergeron J, Mounier C, Joanisse DR, Mauriège P.
PMID: 35000091
J Physiol Biochem. 2022 Jan 09; doi: 10.1007/s13105-021-00855-4. Epub 2022 Jan 09.

Although severe obesity is associated with insulin resistance (IR) and inflammation, secretory function of intra-abdominal adipose tissues and their relationships with IR and inflammation markers remain poorly understood. Aims were to measure gene expression of adipogenic (C/EBPα/β, PPARγ-1/2, SREBP-1c,...

Cite
Clément AA, Lacaille M, Lounis MA, et al. Intra-abdominal adipose depot variation in adipogenesis, lipogenesis, angiogenesis, and fibrosis gene expression and relationships with insulin resistance and inflammation in premenopausal women with severe obesity. J Physiol Biochem. 2022;doi: 10.1007/s13105-021-00855-4.
Clément, A. A., Lacaille, M., Lounis, M. A., Biertho, L. D., Richard, D., Lemieux, I., Bergeron, J., Mounier, C., Joanisse, D. R., & Mauriège, P. (2022). Intra-abdominal adipose depot variation in adipogenesis, lipogenesis, angiogenesis, and fibrosis gene expression and relationships with insulin resistance and inflammation in premenopausal women with severe obesity. Journal of physiology and biochemistry, . https://doi.org/10.1007/s13105-021-00855-4
Clément, Andrée-Anne, et al. "Intra-abdominal adipose depot variation in adipogenesis, lipogenesis, angiogenesis, and fibrosis gene expression and relationships with insulin resistance and inflammation in premenopausal women with severe obesity." Journal of physiology and biochemistry vol. (2022). doi: https://doi.org/10.1007/s13105-021-00855-4
Clément AA, Lacaille M, Lounis MA, Biertho LD, Richard D, Lemieux I, Bergeron J, Mounier C, Joanisse DR, Mauriège P. Intra-abdominal adipose depot variation in adipogenesis, lipogenesis, angiogenesis, and fibrosis gene expression and relationships with insulin resistance and inflammation in premenopausal women with severe obesity. J Physiol Biochem. 2022 Jan 09; doi: 10.1007/s13105-021-00855-4. Epub 2022 Jan 09. PMID: 35000091.
Copy Download .nbib Format: NLM
Rectal Indomethacin Does Not Mitigate the Systemic Inflammatory Response Syndrome in Acute Pancreatitis: A Randomized Trial.

Clinical and translational gastroenterology

Machicado JD, Mounzer R, Paragomi P, Pothoulakis I, Hart PA, Conwell DL, de-Madaria E, Greer P, Yadav D, Whitcomb DC, Lee PJ, Hinton A, Papachristou GI.
PMID: 34704970
Clin Transl Gastroenterol. 2021 Oct 27;12(11):e00415. doi: 10.14309/ctg.0000000000000415.

INTRODUCTION: Experimental data suggest that nonsteroidal antiinflammatory drugs may prevent disease severity and mortality in acute pancreatitis (AP). The aim of this study was to compare the efficacy of rectal indomethacin vs placebo in reducing the systemic inflammatory response...

Cite
Machicado JD, Mounzer R, Paragomi P, et al. Rectal Indomethacin Does Not Mitigate the Systemic Inflammatory Response Syndrome in Acute Pancreatitis: A Randomized Trial. Clin Transl Gastroenterol. 2021;12(11):e00415doi: 10.14309/ctg.0000000000000415.
Machicado, J. D., Mounzer, R., Paragomi, P., Pothoulakis, I., Hart, P. A., Conwell, D. L., de-Madaria, E., Greer, P., Yadav, D., Whitcomb, D. C., Lee, P. J., Hinton, A., & Papachristou, G. I. (2021). Rectal Indomethacin Does Not Mitigate the Systemic Inflammatory Response Syndrome in Acute Pancreatitis: A Randomized Trial. Clinical and translational gastroenterology, 12(11), e00415. https://doi.org/10.14309/ctg.0000000000000415
Machicado, Jorge D, et al. "Rectal Indomethacin Does Not Mitigate the Systemic Inflammatory Response Syndrome in Acute Pancreatitis: A Randomized Trial." Clinical and translational gastroenterology vol. 12,11 (2021): e00415. doi: https://doi.org/10.14309/ctg.0000000000000415
Machicado JD, Mounzer R, Paragomi P, Pothoulakis I, Hart PA, Conwell DL, de-Madaria E, Greer P, Yadav D, Whitcomb DC, Lee PJ, Hinton A, Papachristou GI. Rectal Indomethacin Does Not Mitigate the Systemic Inflammatory Response Syndrome in Acute Pancreatitis: A Randomized Trial. Clin Transl Gastroenterol. 2021 Oct 27;12(11):e00415. doi: 10.14309/ctg.0000000000000415. PMID: 34704970; PMCID: PMC8553238.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 23 entries